As per MRFR analysis, the Photopheresis Product Market Size was estimated at 0.57 (USD Billion) in 2022.
The Photopheresis Product Market Industry is expected to grow from 0.65(USD Billion) in 2023 to 1.9 (USD Billion) by 2032. The Photopheresis Product Market CAGR (growth rate) is expected to be around 12.73% during the forecast period (2024 - 2032).
The Global Photopheresis Market has been witnessing remarkable changes owing to factors like technological advancements, increasing incidences of dermal disorders, and a growing inclination towards custom-made therapies. The development of new technologies, such as extracorporeal photopheresis (ECP), which is more effective and shorter in terms of treatment time, is another factor impacting the market. The increasing emphasis on R&D in this area will also aid in its growth by giving birth to innovative products with efficient photopheresis functionalities. This is expected to assist the market expansion in forthcoming years.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The rising incidence of skin diseases such as cutaneous T-cell lymphoma (CTCL) and atopic dermatitis is a major driver of the Photopheresis Product Market. CTCL is a rare type of non-Hodgkin lymphoma that affects the skin. It is characterized by the presence of abnormal T-cells in the skin, which can lead to the development of red, scaly patches or plaques on the skin. Atopic dermatitis is a chronic inflammatory skin condition that causes dry, itchy, and irritated skin.Both CTCL and atopic dermatitis can be difficult to treat, and photopheresis has been shown to be an effective treatment option for these conditions. The increasing prevalence of skin diseases is due to a number of factors, including the aging population, the rising incidence of obesity, and the increasing use of immunosuppressive drugs. As the population ages, the risk of developing skin diseases increases. Obesity is a major risk factor for the development of CTCL, and the increasing prevalence of obesity is contributing to the rising incidence of this disease.Immunosuppressive drugs are used to treat a variety of conditions, including cancer and autoimmune diseases. These drugs can weaken the immune system, which can make people more susceptible to developing skin diseases. The growing prevalence of skin diseases is creating a significant demand for photopheresis products. Photopheresis is a procedure that involves exposing the patient's blood to ultraviolet (UV) light. This process helps to remove the abnormal T-cells from the blood and can improve the patient's skin condition.The increasing demand for photopheresis products is expected to drive the growth of the Photopheresis Product Market in the coming years.
Technological advancements are also driving the Photopheresis Product Market. In recent years, there have been significant improvements in the design and manufacturing of photopheresis products. These advancements have made photopheresis procedures more efficient, more effective, and more affordable. As a result, photopheresis is now being used to treat a wider range of skin conditions than ever before. One of the most significant technological advancements in the field of photopheresis has been the development of new light sources.Traditional photopheresis procedures use UV light to remove abnormal T-cells from the blood. However, UV light can be harmful to the skin, and it can cause side effects such as sunburn and skin cancer. New light sources, such as excimer lasers, are more precise and less harmful to the skin. This has made photopheresis procedures safer and more effective. Another important technological advancement has been the development of new cell separation techniques.Traditional photopheresis procedures use a centrifuge to separate the abnormal T-cells from the blood. However, this process was not very efficient, and it could result in the loss of some of the normal T-cells. New cell separation techniques, such as magnetic cell sorting, are more efficient and more precise. This has improved the efficacy of photopheresis procedures.
The growing awareness of photopheresis is also driving the Photopheresis Product Market. In the past, photopheresis was a relatively unknown procedure. However, in recent years, there has been a growing awareness of the benefits of photopheresis. This is due in part to the increasing number of studies that have shown the efficacy of photopheresis for treating a variety of skin conditions. The growing awareness of photopheresis is leading to an increase in the number of patients who are requesting photopheresis procedures.This is creating a significant demand for photopheresis products and services. The growing awareness of photopheresis is expected to continue to drive the growth of the Photopheresis Product Market in the coming years.
Disease Type Segment Insights and Overview The disease type segment plays a crucial role in the Photopheresis Product Market, influencing market growth and dynamics. Among the key disease types treated with photopheresis, Cutaneous T-cell lymphoma (CTCL), Graft-versus-Host Disease (GvHD), and Other Diseases hold significant market shares. Cutaneous T-Cell Lymphoma (CTCL): CTCL, a type of non-Hodgkin lymphoma that affects the skin, is a primary indication for photopheresis. The Photopheresis Product Market revenue for CTCL treatment is expected to reach USD 0.42 billion by 2024, growing at a CAGR of 10.5%.The increasing prevalence of CTCL and the efficacy of photopheresis in managing its symptoms drive this growth. Graft-versus-Host Disease (GvHD): GvHD, a potentially life-threatening complication following stem cell or bone marrow transplantation, is another major application of photopheresis. The Photopheresis Product Market segmentation for GvHD is projected to reach USD 0.25 billion by 2024, with a CAGR of 9.8%. The growing number of stem cell transplants and the effectiveness of photopheresis in treating GvHD contribute to this growth.Other Diseases: Other diseases treated with photopheresis include mycosis fungoides, Sezary syndrome, and pemphigus vulgaris. The Photopheresis Product Market data for this segment is estimated to reach USD 0.14 billion by 2024, growing at a CAGR of 8.5%. The rising prevalence of these diseases and the potential benefits of photopheresis in managing their symptoms drive this growth.
Overall, the disease-type segment offers significant opportunities for market growth. The increasing prevalence of CTCL, GvHD, and other diseases, along with the proven efficacy of photopheresis in their management, is expected to fuel the Photopheresis Product Market statistics in the coming years.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Photopheresis Product Market is segmented by product type into cells and plasma. Cells segment held the largest market share of 61.2% in 2023 and is expected to continue its dominance throughout the forecast period. The growth of this segment can be attributed to the increasing prevalence of skin diseases such as cutaneous T-cell lymphoma (CTCL) and atopic dermatitis. The plasma segment, on the other hand, is expected to grow at a faster rate during the forecast period due to its increasing use in the treatment of autoimmune diseases such as rheumatoid arthritis and lupus.The Photopheresis Product Market revenue for cells segment is projected to reach USD 1.02 billion by 2024, growing at a CAGR of 10.2%, while the plasma segment is expected to reach USD 0.67 billion by 2024, growing at a CAGR of 11.8%.
Ex vivo and in vivo are the two main types of photopheresis applications. Ex vivo photopheresis, which involves removing white blood cells from the body, treating them with UVA light, and then returning them to the body, is the most popular technique. In vivo photopheresis, on the other hand, involves administering a photosensitizing agent to the patient and then exposing the blood to UVA light while it is still circulating in the body. In 2023, the ex vivo segment held a dominant share of over 80% of the Photopheresis Product Market revenue due to its established efficacy and safety profile.However, the in vivo segment is expected to grow at a faster CAGR over the forecast period, owing to its potential advantages, such as reduced treatment time and lower risk of side effects. With the rising prevalence of skin disorders such as cutaneous T-cell lymphoma (CTCL) and atopic dermatitis, the Photopheresis Product Market is anticipated to grow significantly in the coming years.
End-User Segment Insights and Overview The Photopheresis Product Market is segmented into various end-users, including hospitals, clinics, and research laboratories. Hospitals account for the largest share of the market, driven by the increasing prevalence of skin disorders, autoimmune diseases, and other conditions treated with photopheresis. Research laboratories are also contributing to market growth as they conduct studies to develop new photopheresis technologies and applications.
The Photopheresis Product Market is segmented regionally into North America, Europe, APAC, South America, and MEA. In 2023, North America contributed the largest market share, followed by Europe and APAC. North America is expected to continue leading the market throughout the forecast period, with a market value of USD 0.42 billion in 2024. This is due to the presence of a large number of key players in the region, such as Therakos, Inc. and Photopheresis Services, LLC. Europe is expected to be the second largest market, with a market value of USD 0.27 billion in 2024.This is due to the increasing prevalence of skin cancer and other skin diseases in the region. APAC is expected to be the fastest-growing market, with a CAGR of 13.2% over the forecast period. This is due to the rising awareness about photopheresis and its benefits in the region. South America and MEA are expected to account for a small share of the global market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Major players in the Photopheresis Product Market industry are continuously focusing on the development of novel products to meet the evolving needs of patients and healthcare providers. Leading Photopheresis Product Market players are investing heavily in research and development (R&D) to stay ahead in the competitive landscape. Furthermore, strategic partnerships, collaborations, and acquisitions are becoming increasingly common in the Photopheresis Product Market as companies seek to expand their product portfolios and gain a competitive edge. The competitive landscape of the Photopheresis Product Market is expected to remain dynamic in the coming years, with new players entering the market and existing players expanding their offerings.Carestream Health is a leading provider of medical imaging and healthcare IT solutions. The company's photopheresis product portfolio includes the Spectra Optia photopheresis system, which is used to treat a variety of skin conditions, including cutaneous T-cell lymphoma (CTCL) and severe atopic dermatitis. Carestream Health has a strong global presence and a well-established customer base. The company is committed to providing innovative and high-quality products and services to its customers.Fresenius Medical Care is a leading provider of products and services for patients with renal diseases. The company's photopheresis product portfolio includes the Theraflex photopheresis system, which is used to treat a variety of skin conditions, including CTCL and severe atopic dermatitis. Fresenius Medical Care has a strong global presence and a well-established customer base. The company is committed to providing innovative and high-quality products and services to its customers.
The Photopheresis Product Market is projected to reach USD 1.9 billion by 2032, exhibiting a CAGR of 12.73% during the forecast period 2024-2032. The market growth is attributed to factors such as the rising prevalence of skin disorders, increasing adoption of photopheresis therapy for various diseases, and growing awareness about the benefits of photopheresis. Key developments in the market include the launch of new products, such as Therakos CellEx System by Fresenius Kabi, and strategic collaborations between market players to expand their product portfolio and geographical reach.
| Report Attribute/Metric | Details |
| Market Size 2022 | 0.57(USD Billion) |
| Market Size 2023 | 0.65(USD Billion) |
| Market Size 2032 | 1.9(USD Billion) |
| Compound Annual Growth Rate (CAGR) | 12.73% (2024 - 2032) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2023 |
| Market Forecast Period | 2024 - 2032 |
| Historical Data | 2019 - 2023 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Terumo BCT, Macopharma, Cord Blood Registry, Octapharma, HemaCare, StemEx, Miltenyi Biotec, Fresenius Kabi, CliniMACS, Biotest AG, Grifols, CryoCord, PhotoPharms, CareDx |
| Segments Covered | Disease Type, Product Type, Application, End-User, Regional |
| Key Market Opportunities | Rising prevalence of autoimmune diseases Technological advancements in photopheresis devices Growing demand for personalized medicine Expansion into emerging markets Increased awareness about photopheresis |
| Key Market Dynamics | Rising prevalence of autoimmune diseases Growing technological advancements Increasing demand for personalized medicine. |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Photopheresis Product Market is expected to be valued at 1.9 USD Billion in 2032.
The Photopheresis Product Market is expected to Register a CAGR of 12.73% from 2024 to 2032.
North America is expected to have the largest market share in the Photopheresis Product Market in 2032.
The Cutaneous T-cell Lymphoma application is expected to have the largest market share in the Photopheresis Product Market in 2032.
Key competitors in the Photopheresis Product Market include Therakos, Inc., MacoPharma, and Fresenius Kabi AG.
Key growth drivers of the Photopheresis Product Market include the increasing prevalence of cutaneous T-cell lymphoma and the rising demand for minimally invasive procedures.
Key challenges facing the Photopheresis Product Market include the high cost of treatment and the limited availability of trained professionals.
Key opportunities for the Photopheresis Product Market include the development of new and more effective photopheresis products and the expansion of the market into new regions.
Key trends in the Photopheresis Product Market include the increasing use of photopheresis in combination with other therapies and the development of new and more convenient photopheresis devices.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
